TipRanks
Go Ultimate55% OFF

Ecolab (ECJ) AI Stock Analysis

8 Followers
DE:ECJ

Ecolab

(XETRA:ECJ)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Recurring integrated modelEcolab’s combination of recurring consumables, installed equipment, digital monitoring, and field service can support durable customer retention and repeat revenue. Long relationships with large multi-site operators also create opportunities to standardize programs and expand wallet share.
Negative Factors
Higher leverageThe sharp increase in debt reduces balance-sheet flexibility and makes Ecolab more sensitive to interest rates and refinancing conditions. Higher leverage can also constrain investment, acquisitions, or shareholder returns if management prioritizes deleveraging over other capital uses.

Ecolab (ECJ) vs. iShares MSCI Germany ETF (EWG)

-10%-5%0%5%10%15%20%25%30%DE:ECJ+28.12%EWG+9.86%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 88.35B
Dividend Yield
0.91%
Average Volume (3M)
53
Price to Earnings (P/E)
42.5
Beta (1Y)
0.63
Revenue Growth
4.02%
EPS Growth
0.99%
Country
Germany
Employees
48,000
Sector
Basic Materials
Sector Strength
61
Industry
Chemicals - Specialty

Ecolab Business Overview & Revenue Model

Company Description

Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through four segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Gl...

Ecolab Earnings Call Summary

Earnings Call Date:Oct 26, 2026(Q3-2026)|% Change Since:7.10%|Next Earnings Date:Feb 15, 2027
Earnings Call SentimentPositive

The call was strongly positive. Ecolab reported accelerating organic sales and operating income growth, broad-based business outperformance, strong momentum in Life Sciences, Digital, Pest and Global High-Tech, and confidence in achieving its 2027 growth and margin commitments. The principal challenges were persistent commodity inflation, a declining Institutional market, Middle East-related headwinds, M&A-related amortization and interest costs, and variability in near-term margins and High-Tech quarterly growth.

Positive Updates

Q3 Organic Sales and Operating Income Growth
Ecolab reported 7% organic sales growth in the third quarter. Organic operating income margin expanded to 19.6%, while organic operating income growth accelerated to 11%.

Negative Updates

Persistent Commodity Cost Inflation
Commodity costs remain high and are expected to stay high in the quarters ahead. Ecolab said continued pricing execution and supply chain management will remain critical to offset the impact.

Company Guidance

For 2027, Ecolab expects organic sales growth at the upper end of its 5% to 7% target, adjusted operating income margin to reach the 20%, and adjusted EPS growth to meet or exceed its long-term adjusted EPS growth target of 12% to 15%; underlying earnings growth is expected to be mid-teens type of growth, with roughly 5 percentage point headwind in the first half and a 5 percentage point tailwind in the second half, while first-half volume is expected to be 1% to 2% and pricing 5% to 6%, followed by second-half volume of 2% to 3% and pricing a bit lower. Life Sciences is expected to deliver 10% to 12% top line growth and reach 30% operating income margin in the next few years; Global High-Tech is expected to grow more than 25% annually, reach $4 billion in sales by 2030 and deliver 25% operating income margin; pricing is expected to remain 5% to 6% through the fourth quarter and probably the first half of next year, while DPC is assumed to stay at a high level till the end of next year.

Ecolab Risk Analysis

Ecolab disclosed 24 risk factors in its most recent earnings report. Ecolab reported the most risks in the "Legal & Regulatory" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Legal & Regulatory - Litigation, compliance, new legislation, and taxation risks

Latest Risks Added

0 New Risks

Ecolab Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

DE:ECJ against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IOSPIOSP73Outperform$2.44B14.2010.41%2.22%4.73%―
HWKNHWKN69Neutral$3.18B37.6715.86%0.49%9.02%3.18%
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
ASHASH61Neutral$3.34B849.330.21%2.18%2.08%―
SCLSCL61Neutral$1.56B371.840.36%2.24%10.02%-90.50%
KWRKWR60Neutral$2.57B27.997.02%1.31%8.68%―

* Basic Materials Sector Average

Performance Comparison

0%20%40%60%DE:ECJASHHWKNIOSPKWRSCLDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:ECJ and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:ECJEcolab277.7057.7826.27%
ASHAshland Global Holdings, Inc.76.4427.5256.25%
HWKNHawkins Inc155.9729.9223.74%
IOSPInnospec80.658.0511.08%
KWRQuaker Chemical157.3027.1520.86%
SCLStepan Company70.6529.1670.28%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.